Given the known association between NAFLD and insulin resistance and obesity, we also tested for an association of PNPLA3 rs139051 polymorphisms with FPG, plasma lipids and BMI. Here, PNPLA3 is linked to metabolic dysfunction-associated steatotic liver disease.